Puget Sound Business Journal: Seattle Biotech AltPep Closes $23M Funding Round For Alzheimer’s Research

Seattle biotech AltPep Corp. closed a $23 million series A funding round last week, which will go toward its Alzheimer’s research.

The biotech is a portfolio company of IntuitiveX, a Seattle life science incubator. Altpep’s board of directors also made several additions, including Adaptive Biotechnologies CEO Chad Robins; David Goel, managing general partner and founded of Matrix Capital Management; and Joel Marcus, executive chairman and founder of Alexandria Real Estate Equities and Alexandria Venture Investments.

View full article in Puget Sound Business Journal.

Interested in Becoming a Community Partner?

The Fourth Industrial Revolution may be one of the most important conversations of our time.

Help bring next-generation technologies to the US by becoming a Seattle Community partner.